KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) FCF Margin: 2009-2025

Historic FCF Margin for Rigel Pharmaceuticals (RIGL) over the last 12 years, with Sep 2025 value amounting to 34.60%.

  • Rigel Pharmaceuticals' FCF Margin fell 460.00% to 34.60% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.16%, marking a year-over-year increase of 1735.00%. This contributed to the annual value of 17.53% for FY2024, which is 2245.00% up from last year.
  • Latest data reveals that Rigel Pharmaceuticals reported FCF Margin of 34.60% as of Q3 2025, which was up 15.20% from 30.03% recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' FCF Margin peaked at 208.67% during Q2 2021, and registered a low of -154.53% during Q1 2022.
  • Over the past 3 years, Rigel Pharmaceuticals' median FCF Margin value was 0.82% (recorded in 2024), while the average stood at 8.66%.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' FCF Margin soared by 29,602bps in 2021, and later crashed by 25,185bps in 2022.
  • Over the past 5 years, Rigel Pharmaceuticals' FCF Margin (Quarterly) stood at -93.41% in 2021, then skyrocketed by 5,055bps to -42.87% in 2022, then spiked by 2,543bps to -17.43% in 2023, then skyrocketed by 4,257bps to 25.14% in 2024, then tumbled by 460bps to 34.60% in 2025.
  • Its last three reported values are 34.60% in Q3 2025, 30.03% for Q2 2025, and -1.67% during Q1 2025.